Nutraceuticals and peripheral glial cells: a possible link?

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Satellite glial cells (SGCs) in the peripheral nervous system are crucial for neuronal support but their interaction with nutraceuticals is understudied.
• SGCs play roles in both normal physiological functions and pathological conditions, including pain.
• Understanding SGCs is vital for developing new therapeutic strategies for neurological disorders.

Purpose of the Study:

• To review existing research on the effects of nutraceuticals on satellite glial cells.
• To explore the potential of nutraceuticals in modulating SGC functions for therapeutic benefit.
• To identify gaps in current knowledge and suggest future research directions.

Main Methods:

• Literature review of studies investigating nutraceuticals and satellite glial cells.
• Analysis of research primarily from rodent models examining SGC-dependent pathways.
• Focus on nutraceuticals impacting SGCs through antioxidant and purinergic signaling mechanisms.

Main Results:

• Several nutraceuticals, including N-acetylcysteine, curcumin, quercetin, osthole, and resveratrol, show potential in alleviating neuropathic pain.
• These effects appear to be mediated through satellite glial cells via antioxidant mechanisms and/or purinergic signaling.
• Limited studies exist, primarily in rodent models, due to challenges in selectively labeling SGCs.

Conclusions:

• Nutraceuticals demonstrate promise as potential therapeutic agents for peripheral neuropathic pain by modulating satellite glial cells.
• Further preclinical and clinical research is essential to validate these findings and explore other SGC-related conditions and nutraceuticals.
• Nutraceuticals may offer novel alternatives for preventing and treating peripheral gliopathies affecting SGCs.